20
Aarti Pharmalabs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
One of their notable products is FLUTICASONE PROPIONATE USP, with a corresponding US DMF Number 22980.
Remarkably, this DMF maintains an Active status since its submission on July 22, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2014, and payment made on March 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II